SAGENT PHARMS INC FDA Approval ANDA 091041

ANDA 091041

SAGENT PHARMS INC

FDA Drug Application

Application #091041

Application Sponsors

ANDA 091041SAGENT PHARMS INC

Marketing Status

Prescription001
Prescription002

Application Products

001INJECTABLE;INJECTIONEQ 0.2MG BASE/ML0OCTREOTIDE ACETATEOCTREOTIDE ACETATE
002INJECTABLE;INJECTIONEQ 1MG BASE/ML0OCTREOTIDE ACETATEOCTREOTIDE ACETATE

FDA Submissions

ORIG1AP2013-11-12
LABELING; LabelingSUPPL3AP2017-07-10STANDARD
LABELING; LabelingSUPPL5AP2019-08-27STANDARD

Submissions Property Types

ORIG1Null42
SUPPL3Null7
SUPPL5Null7

TE Codes

001PrescriptionAP
002PrescriptionAP

CDER Filings

SAGENT PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91041
            [companyName] => SAGENT PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"OCTREOTIDE ACETATE","activeIngredients":"OCTREOTIDE ACETATE","strength":"EQ 0.2MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OCTREOTIDE ACETATE","activeIngredients":"OCTREOTIDE ACETATE","strength":"EQ 1MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"OCTREOTIDE ACETATE","submission":"OCTREOTIDE ACETATE","actionType":"EQ 0.2MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"OCTREOTIDE ACETATE","submission":"OCTREOTIDE ACETATE","actionType":"EQ 1MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.